immunotherapy for recurrent or metastatic hnscc: what are the practical considerations?
Published 2 years ago • 436 plays • Length 33:50Download video MP4
Download video MP3
Similar videos
-
38:21
navigating the challenges of treatment provision in recurrent/metastatic hnscc
-
5:14
immunotherapy for recurrent hnscc
-
3:35
cancer immunotherapy
-
8:58
practical issues surrounding immunotherapy for hnscc
-
1:26
what is immunotherapy? - sarah m. larson, md | ucla health
-
4:41
immunotherapy combinations for hnscc
-
13:56
emerging data with immunotherapy in esophageal squamous cell carcinoma
-
11:57
immunotherapy in hnscc
-
4:06
immunotherapy for head and neck cancer treatment
-
4:42
pembrolizumab for recurrent head and neck squamous cell carcinomas (hnscc)
-
10:59
emerging concepts for immunotherapy in hnscc
-
3:50
managing head and neck cancer (squamous cell carcinoma)
-
2:40
what is immunotherapy?
-
3:02
immunotherapy for cancer: what it is and why it’s used
-
28:48
the changing treatment landscape in recurrent/metastatic squamous cell carcinoma of head & neck
-
1:41
ct guided injection of immunotherapy into a squamous cell carcinoma of the head and neck.
-
2:53
what is immunotherapy?
-
1:45
what is immunotherapy and cellular therapy for cancer care? (stuart wong, md)
-
1:29
what is immunotherapy?